Oxytocin
Also referenced as: Pitocin
A nonapeptide hormone with approved obstetric uses and separate experimental behavioral research.
- Evidence grade
- AStrong Clinical Evidence
Strong Clinical Evidence
- Regulatory status
- FDA Approved for Specific Indication
Approved injections have defined obstetric indications, including medically indicated labor induction or augmentation and postpartum bleeding control; not approved for behavioral enhancement.
- Human data
- Yes
Registered clinical trials exist
- Last reviewed
- October 27, 2026
Overview
A nonapeptide hormone with approved obstetric uses and separate experimental behavioral research.
Approved injections have defined obstetric indications, including medically indicated labor induction or augmentation and postpartum bleeding control; not approved for behavioral enhancement.
A behavioral hypothesis or intranasal research result does not inherit the safety and efficacy of approved obstetric injection.
Why It's Being Studied
- Labor induction
- Postpartum bleeding
- Reproductive physiology
Mechanism of Action
Oxytocin-receptor activation promotes uterine contractions and physiological milk ejection.
Oxytocin-receptor activation promotes uterine contractions and physiological milk ejection. A behavioral hypothesis or intranasal research result does not inherit the safety and efficacy of approved obstetric injection.
From molecular target to clinical evidence
Tap each stage to see what happens.
Background: Clinical Peptide Medicines
Clinical peptide medicines include endocrine treatments, antimicrobial drugs, receptor blockers and targeted diagnostic or cancer agents. They do not share one mechanism or one set of indications.
An approval belongs to a specific medicine and indication. A diagnostic tracer, an antibiotic and a hormone are not interchangeable wellness products; read each profile's own mechanism and prescribing source.
Research Areas & Routes Studied
- Labor induction
- Postpartum bleeding
- Reproductive physiology
- Approved obstetric injection
- Intranasal experimental research
Evidence Summary
Clinical evidence supports obstetric uses, not approval of compounded intranasal products for bonding, autism or sexual dysfunction.
Higher tiers carry more weight. Filled tiers have evidence for Oxytocin; tap to read it.
- Clinical evidence supports obstetric uses, not approval of compounded intranasal products for bonding, autism or sexual dysfunction.
1 cited sources.
- Prescribing label1
Human clinical evidence
- Clinical evidence supports obstetric uses, not approval of compounded intranasal products for bonding, autism or sexual dysfunction.
Reported Adverse Events in Research
- Uterine hyperstimulation or rupture, fetal compromise and water intoxication can be serious.
Limitations of Current Evidence
- A behavioral hypothesis or intranasal research result does not inherit the safety and efficacy of approved obstetric injection.
- Findings apply to the product, route and population studied; they do not establish benefits or safety for unrelated wellness uses or research-vial products.
How to Read This Research
- Is this a single molecule or a family of medicines?
- Is the use diagnostic, therapeutic or investigational?
- Does the quoted outcome match the exact product, formulation and population?
- Use the compound-specific mechanism above; this diagram describes drug development, not a shared biological pathway.
- Historical approval, present availability and off-label use are distinct questions.
- For radiopharmaceuticals and hospital medicines, specialist handling is part of the treatment context.
- Indication
- The condition and population for which a medicine is approved.
- Antagonist
- A compound that blocks activity at a receptor.
- Radiopharmaceutical
- A medicine containing a radioactive isotope for imaging or treatment.
Compare With Other Compounds
| Oxytocin | Trofinetide | |
|---|---|---|
| Evidence grade | A — Strong Clinical Evidence | B — Moderate Human Evidence |
| Regulatory status | FDA Approved for Specific Indication | FDA Approved for Specific Indication |
| Human data | Yes | Yes |
| Clinical trials | Registered trials exist | Registered trials exist |
| Research routes | Approved obstetric injection, Intranasal experimental research | Oral approved medicine |
| Cited sources | 1 | 2 |
Frequently Asked Questions
Research References
- Prescribing label
Oxytocin — prescribing label